Innovating Works

IPSIRIUS

Desconocido
MUTAVAC: Targeting cancer with mutanome based stem cell vaccine IPSIRIUS tramitó un HORIZON EUROPE HORIZON-EIC-2021-PATHFINDERCHALLENGES-01 The successful application of immune checkpoints inhibitors has modified the therapeutic strategies in several cancers but only 30% of patie...
2022-06-17 - 2024-09-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.